Heidi Wang News Today

- First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2- Dosing of first

This year's conference boasts an incredible speaker lineup and several panels of the impact of AI.

Italy’s premier international event promises an exceptional in-person program of talks, presentations, in-depth workshops, and masterclasses designed to inspire, inform, and educate; join industry professionals, thought leaders, students, and enthusiasts in a celebration of the latest in animation, VFX, and games - event runs October 15-20.

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth... | June 2, 2023

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth of

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer...

LGBTQ rights have come a long way. Is there further to go?